Table 1. Demographic, clinical and laboratory variables in subjects with atrial fibrillation and in controls.

Variables	AF Patients (n=100)	Controls (n=121)	p
Age (years) (mean± SD)	73.70± 12.05	74.98±9.63	0.383
M/F	54/46	73/48
SBP (mmHg) (mean± SD)	127.33 ± 15.57	131.28±10.45	0.026
DBP (mmHg) (mean± SD)	71.48±10.36	72.917±9.93	0.295
Weight (Kg) (mean± SD)	75.18±14.24	77.90±11.03	0.111
BMI (kg/m2) (mean± SD)	26.85±4.66	27.67±3.81	0.152
Hypertension (n/%)	84/84	48/39,66	0.001
Diabetes (n/%)	34/34	25/20.66	0.019
Dyslipidaemia (n/%)	35/35	41/33,88	0.093
SHD (n/%)	47/47	30/24,79	0.019
Heart rate (bpm) (mean± SD)	80.01±16.64	88.15±12.39	0.001
Left atrium diameter (mm) (mean± SD)	45.99±9.05	38.47±7.57	0.001
LVEF (%) (mean± SD)	50.39±11.29	55.58±9.40	0.001
Total cholesterol (mMol/L) (mean± SD)	148.94±40.13	133.74±35.17	0.003
LDL cholesterol (mMol/L) (mean± SD)	82.76±33.30	83.75±33.95	0.828
Triglycerides (mmol/L) (mean± SD)	90.52±40.67	84.46±28.57	0.196
HBa1C (mean± SD)	6.16±1.15	5.31±1.44	0.001
Micro albuminuria (mean± SD)	95.56±39.77	61.94±31.73	0.025
eGFR (ml/min) (mean± SD)	72.47± 17.09	70.70± 19.87	0.477
ACE inhibitors or ARB (n/%)	61/61	47/38.84	0.001
Beta blockade (n/%)	50/50	37/30.57	0.003
Calcium channel blockers (n/%)	26/26	33/27.27	0.477
Antiarrhythmic drugs (n/%)	27/27	9/7.43	0.001
Antiplatels drugs (n/%)	37/37	32/26.44	0.109
Anticoagulant drugs (n/%)	53/53	1/0.82	0.001
Diuretic (n/%)	49/49	14/11.57	0.001
Statin (n/%)	34/34	37/30.57	0.665
RHI (mean± SD)	1.76±0.83	2.34±0.68	0.001
IL-18 pg/mL (mean± SD)	442.72±172.34	172.85±109.69	0.001
sIL2Ralfa pg/mL (mean± SD)	867.22±391.40	276.28±95.82	0.001
TNF-alfa pg/mL (mean± SD)	7.85±3.05	2.99±0.97	0.001